Literature DB >> 23203758

Structure-activity studies of lGnRH-III through rational amino acid substitution and NMR conformational studies.

Eleni V Pappa1, Aikaterini A Zompra, Zoi Diamantopoulou, Zinovia Spyranti, George Pairas, Fotini N Lamari, Panagiotis Katsoris, George A Spyroulias, Paul Cordopatis.   

Abstract

Lamprey gonadotropin-releasing hormone type III (lGnRH-III) is an isoform of GnRH isolated from the sea lamprey (Petromyzon marinus) with negligible endocrine activity in mammalian systems. Data concerning the superior direct anticancer activity of lGnRH-III have been published, raising questions on the structure-activity relationship. We synthesized 21 lGnRH-III analogs with rational amino acid substitutions and studied their effect on PC3 and LNCaP prostate cancer cell proliferation. Our results question the importance of the acidic charge of Asp⁶ for the antiproliferative activity and indicate the significance of the stereochemistry of Trp in positions 3 and 7. Furthermore, conjugation of an acetyl-group to the side chain of Lys⁸ or side chain cyclization of amino acids 1-8 increased the antiproliferative activity of lGnRH-III demonstrating that the proposed salt bridge between Asp⁶ and Lys⁸ is not crucial. Conformational studies of lGnRH-III were performed through NMR spectroscopy, and the solution structure of GnRH-I was solved. In solution, lGnRH-III adopts an extended backbone conformation in contrast to the well-defined β-turn conformation of GnRH-I.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23203758     DOI: 10.1002/bip.22123

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  7 in total

1.  Low energy conformations for gonadotropin-releasing hormone with D- and L-amino acid substitutions for Gly 6: possible receptor-bound conformations.

Authors:  Matthew R Pincus; Jannie Woo; Regina Monaco; Jack Lubowsky; Robert P Carty
Journal:  Protein J       Date:  2014-12       Impact factor: 2.371

2.  The low-energy conformations of gonadotropin-releasing hormone in aqueous solution.

Authors:  Matthew R Pincus; Jannie Woo; Regina Monaco; Jack Lubowsky; Matthew J Avitable; Robert P Carty
Journal:  Protein J       Date:  2014-12       Impact factor: 2.371

3.  Low Energy Conformations for S100 Binding Peptide from the Negative Regulatory Domain of p53.

Authors:  Robert P Carty; Bo Lin; Daniel Fridman; Matthew R Pincus
Journal:  Protein J       Date:  2018-12       Impact factor: 2.371

4.  Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice.

Authors:  Ivan Ranđelović; Sabine Schuster; Bence Kapuvári; Gianluca Fossati; Christian Steinkühler; Gábor Mező; József Tóvári
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

5.  Suitability of GnRH Receptors for Targeted Photodynamic Therapy in Head and Neck Cancers.

Authors:  Lilla Pethő; József Murányi; Kinga Pénzes; Bianka Gurbi; Diána Brauswetter; Gábor Halmos; Gabriella Csík; Gábor Mező
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

6.  Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice.

Authors:  Bence Kapuvári; Rózsa Hegedüs; Ákos Schulcz; Marilena Manea; József Tóvári; Alexandra Gacs; Borbála Vincze; Gábor Mező
Journal:  Invest New Drugs       Date:  2016-05-05       Impact factor: 3.850

7.  Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin-GnRH-III conjugates developed for targeted drug delivery.

Authors:  Sabine Schuster; Beáta Biri-Kovács; Bálint Szeder; Viktor Farkas; László Buday; Zsuzsanna Szabó; Gábor Halmos; Gábor Mező
Journal:  Beilstein J Org Chem       Date:  2018-04-04       Impact factor: 2.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.